Clinical Trial Update: Phase II Pazopanib Study in Advanced Dermatofibrosarcomas [Phase 2]

View source ↗

Summary

A Phase II study of pazopanib in advanced dermatofibrosarcoma protuberans was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dermatofibrosarcoma Protuberans

Drugs mentioned

• Pazopanib (Votrient) (Pazopanib)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Dermatofibrosarcomas of DARIER FERRAND(DFSP) | Phase 2 | Status: TERMINATED